Bacillus Calmette-guerin Cell Wall Cytoskeleton Enhances Colon Cancer Radiosensitivity Through Autophagy
Overview
Authors
Affiliations
The cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin (BCG/CWS) is an effective antitumor immunotherapy agent. Here, we demonstrate that BCG/CWS has a radiosensitizing effect on colon cancer cells through the induction of autophagic cell death. Exposure of HCT116 colon cancer cells to BCG/CWS before ionizing radiation (IR) resulted in increased cell death in a caspase-independent manner. Treatment with BCG/CWS plus IR resulted in the induction of autophagy in colon cancer cells. Either the autophagy inhibitor 3-methyladenine or knockdown of beclin 1 or Atg7 significantly reduced tumor cell death induced by BCG/CWS plus IR, whereas the caspase inhibitor z-VAD-fmk failed to do so. BCG/CWS plus IR-mediated autophagy and cell death was mediated predominantly by the generation of reactive oxygen species (ROS). The c-Jun NH(2)-terminal kinase pathway functioned upstream of ROS generation in the induction of autophagy and cell death in HCT116 cells after co-treatment with BCG/CWS and IR. Furthermore, toll-like receptor (TLR) 2, and in part, TLR4, were responsible for BCG/CWS-induced radiosensitization. In vivo studies revealed that BCG/CWS-mediated radiosensitization of HCT116 xenograft growth is accompanied predominantly by autophagy. Our data suggest that BCG/CWS in combination with IR is a promising therapeutic strategy for enhancing radiation therapy in colon cancer cells through the induction of autophagy.
Chang Y, Li J, Liu T, Wei C, Ma L, Nikolenko V World J Gastroenterol. 2024; 30(11):1524-1532.
PMID: 38617452 PMC: 11008416. DOI: 10.3748/wjg.v30.i11.1524.
Emerging role of autophagy in colorectal cancer: Progress and prospects for clinical intervention.
Ma T, Fan Y, Zhao Y, Liu B World J Gastrointest Oncol. 2023; 15(6):979-987.
PMID: 37389106 PMC: 10302997. DOI: 10.4251/wjgo.v15.i6.979.
How autophagy, a potential therapeutic target, regulates intestinal inflammation.
Chen S, Li C, Li W, Liu Q, Hu S, Zhao M Front Immunol. 2023; 14:1087677.
PMID: 37168865 PMC: 10165000. DOI: 10.3389/fimmu.2023.1087677.
Khosravi M, Khazaeil K, KhademiMoghadam F PLoS One. 2022; 17(10):e0275776.
PMID: 36206297 PMC: 9543947. DOI: 10.1371/journal.pone.0275776.
Yu T, Ben S, Ma L, Jiang L, Chen S, Lin Y Front Oncol. 2022; 12:876424.
PMID: 35992821 PMC: 9389459. DOI: 10.3389/fonc.2022.876424.